SHARE
 
Paul M. Harari, MD close
9hHc9jBi3UE
Paul M. Harari, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Paul M. Harari, MD Print Friendly Page

Chair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.

Specialties

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency University of Arizona Medical Center, Tuscon, AZ
Internship University of California-Davis Medical Center, Sacramento, CA
Medical School University of Virginia School of Medicine, Charlottesville, VA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.


PubMed Articles
Amdur RJ Harari PM Dziegielewski PT Mendenhall WM Refining Guidelines Regarding Unilateral Treatment in Patients With Well-lateralized Squamous Cell Carcinoma of the Palatine Tonsil and Multiple Positive Nodes or Extranodal Extension. Pract Radiat Oncol . 2021 Jan 9;
[PubMed ID: 33434692]
Jhawar SR Bonomi M Harari PM Treating Advanced Head and Neck Cancer When Cisplatin Is Not an Option. J Clin Oncol . 2021 Jan 1;39(1):7-12
[PubMed ID: 33275489]
Harari PM Lambert PF Life Beyond COVID: Pay Attention to Viruses. Int J Radiat Oncol Biol Phys . 2020 Oct 1;108(2):348-350
[PubMed ID: 32890509]
Thomson DJ Palma D Guckenberger M Balermpas P Beitler JJ Blanchard P Brizel D Budach W Caudell J Corry J Corvo R Evans M Garden AS Giralt J Gregoire V Harari PM Harrington K Hitchcock YJ Johansen J Kaanders J Koyfman S Langendijk JA Le QT Lee N Margalit D Mierzwa M Porceddu S Soong YL Sun Y Thariat J Waldron J Yom SS Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Radiother Oncol . 2020 Oct;151:314-321
[PubMed ID: 32730830]
Tiwari A Iida M Kosnopfel C Abbariki M Menegakis A Fehrenbacher B Maier J Schaller M Brucker SY Wheeler DL Harari PM Rothbauer U Schittek B Zips D Toulany M Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers. Cancers (Basel) . 2020 Sep 29;12(10)
[PubMed ID: 33003386]
Jagodinsky JC Harari PM Morris ZS The Promise of Combining Radiation Therapy With Immunotherapy. Int J Radiat Oncol Biol Phys . 2020 Sep 1;108(1):6-16
[PubMed ID: 32335187]
Burr AR Harari PM Haasl AM Wieland AM Bruce JY Kimple RJ Hartig GK McCulloch TM Witek ME Clinical outcomes for larynx patients with cancer treated with refinement of high-dose radiation treatment volumes. Head Neck . 2020 Aug;42(8):1874-1881
[PubMed ID: 32057151]
Thomson DJ Palma D Guckenberger M Balermpas P Beitler JJ Blanchard P Brizel D Budach W Caudell J Corry J Corvo R Evans M Garden AS Giralt J Gregoire V Harari PM Harrington K Hitchcock YJ Johansen J Kaanders J Koyfman S Langendijk JA Le QT Lee N Margalit D Mierzwa M Porceddu S Soong YL Sun Y Thariat J Waldron J Yom SS Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. Int J Radiat Oncol Biol Phys . 2020 Jul 15;107(4):618-627
[PubMed ID: 32302681]
Fisher MM SenthilKumar G Hu R Goldstein S Ong IM Miller MC Brennan SR Kaushik S Abel L Nickel KP Iyer G Harari PM Kimple RJ Baschnagel AM Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas. Int J Radiat Oncol Biol Phys . 2020 Jul 15;107(4):793-803
[PubMed ID: 32298810]
Lugo-Cintrón KM Ayuso JM White BR Harari PM Ponik SM Beebe DJ Gong MM Virumbrales-Muñoz M Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment. Lab Chip . 2020 May 7;20(9):1586-1600
[PubMed ID: 32297896]
Witek ME Harari PM Emphasize Treatment of Known Disease Rather Than Past Footprints. Int J Radiat Oncol Biol Phys . 2020 Apr 1;106(5):904
[PubMed ID: 32171461]
Rydzewski NR Harari PM Hartig GK Francis D Witek ME Clinical Implications of Scleroderma in the Decision for Radiotherapy-Based Larynx Preservation. JAMA Otolaryngol Head Neck Surg . 2020 Mar 1;146(3):308-309
[PubMed ID: 31830220]
Ayuso JM Gong MM Skala MC Harari PM Beebe DJ Human Tumor-Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells. Adv Healthc Mater . 2020 Feb;9(3):e1900925
[PubMed ID: 31894641]
Shaverdian N Yeboa DN Gardner L Harari PM Liao K McCloskey S Tuli R Vapiwala N Jagsi R Nationwide Survey of Patients' Perspectives Regarding Their Radiation and Multidisciplinary Cancer Treatment Experiences. J Oncol Pract . 2019 Dec;15(12):e1010-e1017
[PubMed ID: 31747336]
Gong MM Lugo-Cintron KM White BR Kerr SC Harari PM Beebe DJ Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function. Biomaterials . 2019 Sep;214:119225
[PubMed ID: 31154151]
Harari PM Open the Gates for Treatment De-Intensification in Head and Neck Cancer. J Clin Oncol . 2019 Aug 1;37(22):1854-1855
[PubMed ID: 31194612]
Thompson JD Avey GD Wieland AM Harari PM Glazer TA McCulloch TM Hartig GK Auriculotemporal Nerve Involvement in Parotid Bed Malignancy. Ann Otol Rhinol Laryngol . 2019 Jul;128(7):647-653
[PubMed ID: 30894024]
Burr AR Harari PM Ko HC Bruce JY Kimple RJ Witek ME Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer. Oral Oncol . 2019 May;92:52-56
[PubMed ID: 31010623]
Bowen RC Ko HC Avey GD Hartig GK Hu R Harari PM Lucarelli MJ Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review. Pract Radiat Oncol . 2019 May;9(3):136-141
[PubMed ID: 30731273]
Gillison ML Trotti AM Harris J Eisbruch A Harari PM Adelstein DJ Jordan RCK Zhao W Sturgis EM Burtness B Ridge JA Ringash J Galvin J Yao M Koyfman SA Blakaj DM Razaq MA Colevas AD Beitler JJ Jones CU Dunlap NE Seaward SA Spencer S Galloway TJ Phan J Dignam JJ Le QT Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet . 2019 Jan 5;393(10166):40-50
[PubMed ID: 30449625]